| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
RESEARCH AND PRACTICE |
Michael Huncharek is with the Division of Radiation Oncology, Department of Clinical Oncology, Marshfield Clinic Cancer Center, Marshfield, Wis; the Meta-Analysis Research Group, Stevens Point, Wis; and St. Michael's Hospital Cancer Center, Stevens Point. Bruce Kupelnick is with the Meta-Analysis Research Group, Stevens Point.
Correspondence: Requests for reprints should be sent to Michael Huncharek, MD, MPH, FACA, Director, Meta-Analysis Research Group, 2740 Sunset Blvd, Stevens Point, WI 54481 (e-mail: metaresearch{at}hotmail.com).
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONCONCLUSIONSReferences |
|---|
Objectives. This study examined the methodology of epidemiological studies that suggest use of topical sunscreen preparations is associated with increased risk of malignant melanoma.
Methods. We pooled data from observational studies using a general variance–based meta-analytic method that employed confidence intervals (previously described). The outcome of interest was a summary relative risk (RR) reflecting the risk of melanoma associated with sunscreen use versus nonuse. Sensitivity analyses were performed when necessary to explain any observed statistical heterogeneity.
Results. Combining studies that used nonheterogeneous data yielded a summary RR of 1.01, indicating no association between sunscreen use and development of malignant melanoma.
Conclusions. The available epidemiological data do not support the existence of a relationship between topical sunscreen use and an increased risk of cutaneous malignant melanoma. (Am J Public Health. 2002;92:1173–1177)
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONCONCLUSIONSReferences |
|---|
Sunscreens are able to delay sunburns and to reduce some UV-induced skin lesions, such as nonmelanoma tumors in rodents, local immunological depression, mutations of the p53 gene in keratinocytes, and the incidence of actinic keratoses in humans. As a consequence, sunscreen use is often recommended as a sun protection method, although its true impact on melanoma prevention remains obscure.
Despite uncertainties in the available epidemiological data, experimental evidence using both animal models and humans suggests that sunscreen preparations capable of reducing exposure to UVB radiation from the sun can prevent melanoma.2 Regrettably, this finding has not been universal. In fact, some investigators suggest that sunscreen use could be a risk rather than a protective factor for malignant melanoma.1 Although it is considered unlikely that available sunscreen preparations contain compounds with carcinogenic effects, other factors may account for this observed relationship; they include uncontrolled confounding caused by host factors and behavioral factors, such as increased sun exposure among patients who use sunscreen preparations.
This article presents the results of a meta-analysis designed to examine the impact of sunscreen use on melanoma risk. In addition to calculating an overall summary estimate of effect, the analysis also explores characteristics of the included studies that may contribute to heterogeneity of observed outcome. The resulting data may provide a clearer understanding of the role of sunscreen in preventing malignant melanoma.
|
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONCONCLUSIONSReferences |
|---|
We used a data extraction form designed for recording relevant information from each selected report. Two researchers performed data extraction, with differences in extraction forms resolved by consensus. Other data collected but not included in the eligibility criteria were number of patients in each study, study odds ratios and 95% confidence intervals (CIs), and type of statistical adjustments made, if any, by individual study authors.
Literature Search
Information retrieval was performed with previously described methods.3 Briefly, we conducted a MEDLARS search of literature published between January 1966 and December 1999, as well as a review of CancerLit and the CD-ROM version of Current Contents. The search criteria included all languages. If a series of articles was published, all data were retrieved from the most recent article. The literature search also included hand searches of bibliographies of published reports, review articles, and textbooks.
The initial citations (in the form of abstracts) from this literature search were screened by a physician–investigator to exclude those that did not meet protocolspecified inclusion criteria. Reasons for rejection included studies of designs other than case–control; cohort or randomized controlled trials; animal or in vitro studies; studies including nonmelanoma skin cancer patients not stratified by tumor type; abstracts; and review articles. Copies of full articles for the remaining citations were obtained and screened according to the following additional eligibility criteria: (1) published case–control or cohort studies, (2) studies enrolling adult patients only (i.e., 
18 years of age), (3) availability of data on frequency of sunscreen use, (4) specified selection criteria for case and control subjects, and (5) availability of data on the outcome of interest (i.e., proportion of patients with a diagnosis of malignant melanoma).
Statistical Analysis
We performed data analysis according to meta-analytic procedures described by Greenland.5 This method of meta-analysis is a general variance–based method employing confidence intervals. Because the variance estimates are based on the adjusted measures of effect and on the 95% confidence interval for the adjusted measures, the confidence interval methods do not ignore confounding factors and are the preferred methodology for nonrandomized data.
For each included study, we derived odds ratios reflecting the risk of developing malignant melanoma associated with sunscreen use and determined the natural logarithm of the estimated relative risk (RR) for each data set followed by an estimate of the variance. We used the estimate of the 95% confidence interval from each study to calculate the variance of each study's measure of effect.
We calculated a weight for each included study as 1/variance followed by a summation of the weights. We then determined the product of the study weight and the natural logarithm of the estimated relative risk and performed a summation of these products. Finally, we calculated a summary RR and 95% confidence interval.5
Before estimation of the summary RR, we performed a statistical test for heterogeneity (Q). This procedure tests the hypothesis that the effect sizes are equal in all studies.3 If Q exceeds the upper-tail critical value of the 
2 distribution at k – 1 degrees of freedom (where k is the number of studies analyzed or the number of statistical comparisons), the observed variances in study effect sizes are significantly greater than would be expected by chance if all studies shared a common population effect size. If the hypothesis that the studies are homogenous is rejected, the studies are not measuring an effect of the same size, and calculation of a pooled estimate of effect must be done cautiously. Possible explanations for the observed heterogeneity must then be sought to provide the most rational interpretation of the summary RR. Therefore, we performed sensitivity and/or further stratified analyses as needed based on the magnitude of Q; these analyses are discussed below.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONCONCLUSIONSReferences |
|---|
Table 1
provides an overview of the 11 case–control studies in the meta-analysis. Overall, the 11 study reports encompassed a total of 9 067 patients. Also shown in the table are the odds ratios calculated for each individual report included in the pooled analysis, along with its 95% confidence interval. An odds ratio greater than 1.0 indicates an increased risk of melanoma associated with sunscreen use. Frequency of sunscreen use is given as noted by the authors of each study. The most frequent reported use was compared with "never used" in the pooled analysis.
|
). With 10 degrees of freedom, this yielded a P value of < .001, a highly significant result. A Q of this magnitude indicates that the pooled studies are heterogeneous—that is, the studies are not measuring an effect of the same size. Therefore, the validity of the summary RR is questionable, and sources of heterogeneity needed to be sought.
|
, all but 2 studies adjusted for potential confounders. The analyses by Klepp et al.10 and Graham et al.11 found a positive association between sunscreen use and increased melanoma risk. A sensitivity analysis we performed excluded both of these reports from the meta-analysis. Recalculation of Q yielded a value of 31.2 (P < .001), which indicated that heterogeneity remained despite removal of these data from the analysis (i.e., other factors were accounting for the variation across studies).
Our examination of the data presented in Table 2 showed that the study by Rodenas et al.16 had a variance substantially greater than that of any other study in the pooled analysis (0.674). An additional sensitivity analysis, omitting these data from the calculation of a summary RR, yielded a Q of 37.7; with 9 degrees of freedom, the corresponding P value was < .001. A Q of this magnitude indicates persistent heterogeneity.
Table 3 outlines selection criteria for case and control subjects and also indicates whether study data were derived from population-based or hospital-based sources. Seven studies used hospital-derived case and control patients, totaling 4 231 subjects.6,9–11,14–16 Because the source of study subjects may bias results through such factors as referral patterns, we stratified the available data to explore this possibility. We pooled the 4 reports that used population registry–derived subjects7,8,12,13 and calculated a Q statistic (4 836 study subjects total); Q equaled 4.9 (P = .18). With 3 degrees of freedom, this result was not statistically significant—that is, the data were not heterogeneous and could therefore be pooled to calculate a summary RR. The resultant summary RR was 1.01 (95% CI = 0.46, 2.28), a statistically nonsignificant result. These data failed to show any relationship between sunscreen use and increased risk of melanoma.
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONCONCLUSIONSReferences |
|---|
If solar radiation is a primary risk factor for malignant melanoma, it is reasonable to conclude that reducing sun exposure via topical sunscreen use would be associated with reduced disease risk. However, the available epidemiological data are contradictory. In fact, the majority of studies suggest that sunscreen use is associated with an increased melanoma risk (see, e.g., studies cited in references 9 and 10). To address this uncertainty, we designed the present study to systematically evaluate the available data using rigorous meta-analytic techniques.
By pooling data from 11 case–control studies meeting protocol inclusion criteria (yielding a statistically nonsignificant summary odds ratio of 1.11), we demonstrated that sunscreen use is not associated with an increased risk of developing malignant melanoma. Unfortunately, further evaluation showed the data to be highly heterogeneous (i.e., the available studies are not measuring an effect size of the same magnitude), thereby making the validity of the summary odds ratio questionable. We then explored reasons for the observed heterogeneity.
Several constitutional factors are accepted as important risk factors for melanoma; these include presence of nevi, having red or fair hair color, freckling, and having blue eye color.14 Failure to control for possible confounders could certainly contribute to the observed statistical heterogeneity. Two of the studies used in the meta-analysis10,11 did not adjust for such factors. Nonetheless, our sensitivity analysis indicated that heterogeneity remained even when the data from Klepp et al. and Graham et al. were dropped from the pooled analysis.
Our careful review of study designs and selection criteria for case and control subjects suggested that the source of study subjects might contribute to a biased estimate of effect (i.e., individual study odds ratios). We found that data from the 4 studies that used population registry–derived subjects7,8,12,13 were statistically homogeneous compared with data from studies that used hospital-derived databases. This result provided strong evidence that selection bias is an important factor contributing to the spurious finding, seen in much of the literature, of a positive association between sunscreen use and melanoma development.
Hospital-derived data are problematic because referral patterns differ widely depending on hospital location, type of facility (e.g., university vs community hospital), and practice patterns, among other factors. In addition, some studies did not provide adequate information on control patient selection. For instance, Rodenas et al.16 reported that "controls were selected from the visitors to the hospital on a random basis" without providing details of the "random" selection process. Autier et al.15 selected case subjects from 5 collaborating hospitals; they noted that "controls were randomly chosen in the same municipality as the cases." Again, no further details are provided on what constituted "random" selection.
Referral patterns may influence study results. If referral patterns among hospitals in a given city or region differ, the overreferral of exposed cases to one hospital implies an underreferral of exposed cases to the others. Due to "differential referral," a factor may be associated with increased disease risk in one hospital-based study and may be protective in another. In an individual study, pooling data across hospitals helps to eliminate bias from differential admission of cases. Pooling data from several sources in a meta-analysis, as done in the study reported here, has partially accomplished this. Although many individual hospital-based studies showed a positive association between sunscreen use and melanoma risk, the pooled analysis indicated that this finding was spurious.
Other factors that may affect outcome in case–control studies include "ascertainment bias" and misclassification of exposure status (in this case, sunscreen use). One factor not considered in the available studies is the possible influence of socioeconomic status (SES). Melanoma tends to affect white-collar, educated, and urban individuals. SES is known to affect recall of some types of information and could play a role in the studies examined in our analysis in which SES was not generally accounted for.20
These factors may all contribute to the wide variation in outcome observed across studies that used hospital registries. In contrast, data from more than 4 800 patients enrolled in population-based case–control studies showed no such variation (i.e., the data were not heterogeneous and could reliably be combined in a meta-analysis). The resulting summary RR of 1.01 (95% CI = 0.46, 2.28) provides strong evidence for a lack of any positive association between sunscreen use and increased melanoma risk.
|
CONCLUSIONS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONCONCLUSIONSReferences |
|---|
Nonetheless, because sunlight remains the most important recognized etiological factor in this disease, methods to reduce exposure (including use of topical sunscreens) appear to be a rational approach to disease prevention and risk reduction. We undertook the present meta-analysis to address the counterintuitive findings of multiple case–control studies that suggest sunscreen use as a risk factor for malignant melanoma. The largely positive association seen in the existing literature appears to be due to bias inherent in study designs and uncontrolled confounding.
It is our hope that the results of the present analysis will contribute to the design of future studies addressing this issue. Until more conclusive data are available, recommending use of sunscreens as a cancer prevention strategy would appear to be prudent.
|
Acknowledgments |
|---|
The authors thank Dr Henry Klassen and Lamar Wheeler for assistance with data extraction.
|
Footnotes |
|---|
Accepted for publication September 24, 2000.
|
References |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONCONCLUSIONSReferences |
|---|
2. Osterlind A. Epidemiology of malignant melanoma in Europe. Acta Oncol. 1992;31(8):903–908.[Medline]
3. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. New York, NY: Academic Press; 1985.
4. Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York, NY: Russell Sage Foundation; 1994.
5.
Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1–30.
6. Espinoza Arranz J, Sanchez Hernandez JJ, Bravo Fernandez P, et al. Cutaneous malignant melanoma and sun exposure in Spain. Melanoma Res. 1999;9(2):199–205.[Medline]
7.
Holly EA, Aston DA, Cress RD, et al. Cutaneous melanoma in women, I: exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol. 1995;141(10):923–933.
8. Westerdahl J, Olsson H, Masback A, et al. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res. 1995;5(1):59–65.[Medline]
9. Wolf P, Quehenberger F, Mullegger R, et al. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study. Melanoma Res. 1998;8(4):370–378.[Medline]
10. Klepp O, Magnus K. Some environmental and bodily characteristics of melanoma patients. A case-control study. Int J Cancer. 1979;23(4):482–486.[Medline]
11.
Graham S, Marshall J, Haughey B, et al. An inquiry into the epidemiology of melanoma. Am J Epidemiol. 1985;122(4):606–619.
12. Holman CD, Armstrong BK, Heenan PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst. 1986;76(3):403–414.
13. Osterlind K, Tucker MA, Stone BJ, et al. The Danish case-control study of cutaneous malignant melanoma, II: the importance of UV-light exposure. Int J Cancer. 1988;42(3):319–324.[Medline]
14. Beitner H, Norell SE, Ringborg U, et al. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br J Dermatol. 1990;122(1):43–51.[Medline]
15. Autier P, Dore JF, Schifflers E, et al. Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group. Int J Cancer. 1995;61(6):749–755.[Medline]
16. Rodenas JM, Delgado-Rodriguez M, Herranz MT, et al. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control. 1996;7(2):275–283.[Medline]
17. Herzfeld PM, Fitzgerald EF, Hwang SA, Stark A. A case-control study of malignant melanoma of the trunk among white males in upstate New York. Cancer Detect Prev. 1993;17(6):601–608.[Medline]
18. Autier P, Dore JF. Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group, European Organisation for Research and Treatment of Cancer. Int J Cancer. 1998;77(4):533–537.[Medline]
19. Ries LAG, Kosary CL, Hankey BF, et al. SEER Cancer Statistics Review: 1973–1994. Bethesda, Md: National Cancer Institute; 1997. NIH publication 97-2789.
20. International Agency for Research on Cancer. Solar and Ultraviolet Radiation. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 55. Lyon, France: IARC: 1992.
21. Glass R, Johnson B, Vessey M. Accuracy of recall of histories of oral contraceptive use. Br J Prev Soc Med. 1974;28(4):273–275.[Medline]
This article has been cited by other articles:
|
|
 |
|
  S. N. Markovic, L. A. Erickson, R. D. Rao, R. R. McWilliams, L. A. Kottschade, E. T. Creagan, R. H. Weenig, J. L. Hand, M. R. Pittelkow, B. A. Pockaj, et al. Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis Mayo Clin. Proc., March 1, 2007; 82(3): 364 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dupuy, A. Dunant, J.-J. Grob, and for Reseau d'Epidemiologie en Dermatologie Randomized Controlled Trial Testing the Impact of High-Protection Sunscreens on Sun-Exposure Behavior Arch Dermatol, August 1, 2005; 141(8): 950 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bauer, P. Buttner, T. S. Wiecker, H. Luther, and C. Garbe Effect of Sunscreen and Clothing on the Number of Melanocytic Nevi in 1,812 German Children Attending Day Care Am. J. Epidemiol., April 1, 2005; 161(7): 620 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. O'Riordan, K. B. Lunde, J. Urschitz, and K. Glanz A Noninvasive Objective Measure of Sunscreen Use and Reapplication Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 722 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Bigby The End of the Sunscreen and Melanoma Controversy? Arch Dermatol, June 1, 2004; 140(6): 745 - 746. [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Stern Treatment of Photoaging N. Engl. J. Med., April 8, 2004; 350(15): 1526 - 1534. [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Dennis, L. E. Beane Freeman, and M. J. VanBeek Sunscreen Use and the Risk for Melanoma: A Quantitative Review Ann Intern Med, December 16, 2003; 139(12): 966 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Marshall, C. Poole, and A. E. Waller SUNSCREEN USE AND MALIGNANT MELANOMA RISK: THE JURY IS STILL OUT Am J Public Health, January 1, 2003; 93(1): 11 - 12. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
